tiprankstipranks
Advertisement
Advertisement
Gossamer Bio’s Seralutinib Future in Doubt After PROSERA Miss in PAH Raises FDA, Funding and Viability Risks
PremiumCompany AnnouncementsGossamer Bio’s Seralutinib Future in Doubt After PROSERA Miss in PAH Raises FDA, Funding and Viability Risks
21d ago
Gossamer Bio reports Q4 EPS (21c), consensus (20c)
Premium
The Fly
Gossamer Bio reports Q4 EPS (21c), consensus (20c)
22d ago
Stagflation Risk Is Back — These 3 Stocks Can Help Defend Your Portfolio
Premium
Market News
Stagflation Risk Is Back — These 3 Stocks Can Help Defend Your Portfolio
27d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/25/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—2/25/26
1M ago
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
Premium
The Fly
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
1M ago
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
Premium
Market News
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
1M ago
Gossamer Bio downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyGossamer Bio downgraded to Market Perform from Outperform at Leerink
1M ago
Gossamer Bio downgraded to Underweight from Overweight at Barclays
Premium
The Fly
Gossamer Bio downgraded to Underweight from Overweight at Barclays
1M ago
Gossamer Bio downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Gossamer Bio downgraded to Market Perform from Outperform at Leerink
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100